Tech Talks Daily6 Sep 2024

3016: How Creyon Bio is Using AI to Transform Drug Development

In this episode, I have an insightful conversation with Chris Hart, the CEO of Creyon Bio, to dive into how artificial intelligence is reshaping drug development.

Creyon Bio is pioneering the use of AI to engineer Oligonucleotide-Based Medicines (OBMs), prioritizing safety in their approach to creating effective treatments. By applying cutting-edge technology, the company is able to streamline the identification of safe medicines, offering a more efficient path to drug discovery.

One of the most compelling examples of their work is the recent treatment of a baby boy diagnosed with an ultra-rare disease caused by a mutation in the TNPO2 gene. In just 13 months, Creyon Bio developed a tailored treatment that marked a major milestone in the world of personalized medicine.

Chris shares the story of this breakthrough, highlighting the role AI played in rapidly creating and testing a selective lock nucleic acid (LNA) antisense oligo, which led to significant improvements in the child's health.

We also explore how Creyon Bio's AI-driven platform addresses common challenges in drug development, from enhancing safety to optimizing delivery. Chris delves into how AI helps analyze complex data sets, enabling the rapid progression from identifying a target to developing a lead compound. This innovation is not only revolutionizing timelines but also increasing the probability of success in the often unpredictable world of biotech.

Tune in to hear Chris's valuable insights on the future of AI in medicine, the challenges the industry faces, and how Creyon Bio is pushing the boundaries of what's possible in drug engineering. Could AI be the key to accelerating life-saving treatments for rare diseases?

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2000)

Current 2026: Why Confluent's Streamhouse Could Solve AI's Real-Time Data Problem

What happens when an AI agent makes a business decision using information that's already out of date? It's a question I wanted to put to Stephen Deasy, CTO of Confluent, when we met at Current 2026 in...

5 Nov 22min

Bringing enterprise AI inference on premises with Scality

What should a business consider before moving AI inference onto infrastructure it owns? In this episode of Tech Talks Daily, I speak with Paul Speciale, Chief Marketing Officer at Scality, about the d...

4 Nov 19min

Electrifying Collection Fleets and Improving Driver Safety With Republic Services

How do you introduce electric vehicles and AI-assisted safety technology into a collection fleet that customers depend on every day? On Tech Talks Daily, I'm joined by Brett Rogers, Vice President of ...

3 Nov 26min

Building Trust in Production AI Agents With Caylent.

What would make you comfortable giving an AI agent the authority to act inside a live business process? In this episode of Tech Talks Daily, I speak with Valerie Henderson, CEO of Caylent, about what ...

2 Nov 26min

Connecting AI Fall Detection With Care Workflows at KamiVision.

What makes an AI fall alert useful to the person who needs help and the team responsible for responding? In this episode of Tech Talks Daily, I speak with Mike Link, chief operating officer at KamiVis...

1 Nov 25min

What Proof of Reserves Can Tell You With LeveX

What can a crypto exchange's proof of reserves establish, and what might still be missing from the picture? On Tech Talks Daily, I'm joined by Harvey Liu, co-founder and CEO of LeveX, to discuss trans...

31 Okt 27min

Reducing IT Firefighting With ControlUp

What needs to happen before an IT team can trust an AI agent to resolve a problem rather than simply report it? In this episode of Tech Talks Daily, I welcome Jed Ayres, CEO of ControlUp, and Gadi Fel...

31 Okt 28min

Making AI the ERP Interface With NetSuite

When would you trust your ERP system to move from answering a question to carrying out the work? Recording at SuiteWorld in Las Vegas, I spoke with Brian Chess, who leads AI product and technology for...

30 Okt 23min